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Among Long-Term Survivors of Cardiac Arrest
Peter W. Groeneveld, MD, MS; Paul A. Heidenreich, MD, MS; Alan M. Garber, MD, PhD
Background—It is unknown whether white and black Medicare beneficiaries have different rates of cardiac procedure
utilization or long-term survival after cardiac arrest.
Methods and Results—A total of 5948 elderly Medicare beneficiaries (5429 white and 519 black) were identified who
survived to hospital discharge between 1990 and 1999 after admission for cardiac arrest. Demographic, socioeconomic,
and clinical information about these patients was obtained from Medicare administrative files, the US census, and the
American Hospital Association’s annual institutional survey. A Cox proportional hazard model that included
demographic and clinical predictors indicated a hazard ratio for mortality of 1.30 (95% CI 1.09 to 1.55) for blacks aged
66 to 74 years compared with whites of the same age. The addition of cardiac procedures to this model lowered the
hazard ratio for blacks to 1.23 (95% CI 1.03 to 1.46). In analyses stratified by race, implantable cardioverter-
defibrillators (ICDs) had a mortality hazard ratio of 0.53 (95% CI 0.45 to 0.62) for white patients and 0.50 (95% CI 0.27
to 0.91) for black patients. Logistic regression models that compared procedure rates between races indicated odds ratios
for blacks aged 66 to 74 years of 0.58 (95% CI 0.36 to 0.94) to receive an ICD and 0.50 (95% CI 0.34 to 0.75) to receive
either revascularization or an ICD.
Conclusions—There is racial disparity in long-term mortality among elderly cardiac arrest survivors. Both black and white
patients benefited from ICD implantation, but blacks were less likely to undergo this potentially life-saving procedure.
Lower rates of cardiac procedures may explain in part the lower survival rates among black patients. (Circulation. 2003;
108:286-291.)
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M
ore than 340 000 cardiac arrests occur annually in the
United States, and 90% of patients are older than 65
years of age.1 Among the 2% to 21% of patients who
survive,2 the relationship of race to long-term mortality is
poorly understood. Findings vary in previous studies of race
and short-term survival after cardiac arrest. Differences in
survival to hospital discharge were found between whites and
blacks in Chicago, Ill,3 but no such disparity was observed in
suburban Michigan.4 Although sizable registries of long-term
survivors have been compiled in clinical trials,5,6 these may
not reflect survival in the general population. Blacks have a
higher incidence of cardiac arrest,7 yet the largest
community-based survival study was conducted in a popula-
tion with fewer than 2% nonwhites.8,9 Other survival studies
in localities such as Rotterdam, the Netherlands, or Seattle,
Wash, had very few black patients.10,11
Racial disparity in revascularization for coronary artery
disease is the subject of several reports.12,13 Some investiga-
tors have noted that lower revascularization rates among
black patients were accompanied by reduced long-term sur-
vival.12 With mounting evidence that implantable
cardioverter-defibrillators (ICDs) can improve survival after
cardiac arrest,6 the annual number of implants has increased
substantially.14 It is unknown whether there is a racial
difference in the likelihood that cardiac arrest survivors will
receive ICDs. In the present study, we examined Medicare
records to assess whether there is racial disparity in the use of
life-saving procedures after cardiac arrest and whether differ-
ences in procedure rates may contribute to black-white
differences in long-term mortality.
Methods
The primary data sources were Medicare Provider Analysis and
Review (MEDPAR) administrative records from a random 20%
selection of all Medicare beneficiaries from 1990 to 1999. We
established a cohort of long-term survivors who were hospitalized
with an admission diagnosis of ventricular fibrillation or cardiac
arrest (International Classification of Diseases, Ninth Revision,
Clinical Modification codes 427.4, 427.41, and 427.5) and survived
to discharge. Admission diagnosis was a selection criterion to
preserve the sequence between the presenting cardiac arrest and
subsequent procedures performed during the index hospitalization
and to minimize the number of patients with cardiac arrest as a
complication of medical care. All patients were white or black, aged
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emergency departments.
Exclusion Criteria
After forming the initial cohort, we excluded patients with any prior
ventricular fibrillation, cardiac arrest, electrophysiological study, or
ICD implantation. Exclusion criteria included ambiguous date of
death, uncertain discharge destination, noncontinuous Medicare
enrollment, absence from the Medicare enrollment database, or
Medicare coverage for less than 1 year before the index admission
(these records were used to assess comorbidity). Because the US
census and the American Hospital Association were sources of
linked data, we removed patients who resided in ZIP codes for which
census data were unavailable or who were admitted to nonpartici-
pating hospitals in the American Hospital Association’s annual
institutional survey.
Demographic Variables
Demographic information was abstracted from the Medicare enroll-
ment database; herein, age and gender were determined from birth
record documentation used in Social Security applications, whereas
race was self-reported. Because preliminary analyses revealed a
nonlinear effect of age on survival, we modeled age as a binary
categorical variable in which patients were classified as younger or
older than 75 years; this divided our cohort into approximately equal
halves. Because socioeconomic factors can influence the relationship
between quality of health care and outcomes,15 we estimated
educational attainment and income by matching the subject’s race
and ZIP code to race-specific median education and per capita
income as reported, by ZIP code, in the 1990 census. Income was
adjusted for regional variation in cost of living.16 Although ZIP code
data cannot accurately estimate the socioeconomic status of individ-
uals, such data have been used effectively in prior studies to control
for socioeconomic variation among communities.17 We determined
Medicare Part B and health maintenance organization (HMO)
enrollment from the Medicare enrollment database. Using American
Hospital Association survey data, we identified characteristics (eg,
academic affiliation) of each admitting hospital.
Preexisting Diagnoses and Comorbidities
The index MEDPAR record was linked with all Medicare records for
hospitalization and outpatient medical care that occurred within 1
year before the index admission. Preexisting coronary artery disease
(codes 410 to 411) and congestive heart failure (CHF; code 428)
were determined from these records. To risk-stratify patients for
noncardiac comorbidity, we used Romano’s adaptation of the Charl-
son index to assign a comorbidity score to each subject.18,19
Index Hospitalization Variables
Medical events during the index hospitalization, such as admission
for ventricular fibrillation (versus cardiac arrest) or any coding for
acute myocardial infarction (AMI; code 410), cardiac ischemia
(411), CHF (428), or anoxic brain injury (348.1), were obtained from
the index MEDPAR record. Length of stay and discharge destination
were also abstracted. Because the Medicare population and the
effectiveness of therapies likely changed over the period from 1990
to 1999, we included year of admission in our models to control for
time trends. Because patients who receive procedures may also
benefit from related aspects of medical care (eg, access to specialists)
that could lower mortality, we used a 20% sample of MEDPAR
records from 1990 to 1999 to identify institutions performing ICD
implantation and/or revascularization during a particular year. We
thereby designated patients as having been admitted to an ICD
hospital and/or a revascularization hospital.
Outcomes
The primary outcome of interest, all-cause mortality, was determined
from the annual Medicare enrollment database, which was cross-
referenced to the Social Security Death Master File. Patients present
in the 1999 enrollment database without a death indicator were
censored at December 31, 1999. Patients without a death indicator
who did not appear in the 1999 database were censored at the
termination date for Medicare Part A coverage. The dates of ICD
implantation (procedure codes 37.94 or 37.96), percutaneous coro-
nary intervention (36.0), and CABG (36.1) were determined from the
index and all subsequent MEDPAR records through 1999.
Multivariate Survival Analyses
We constructed 3 multivariate Cox proportional hazard models. The
proportional hazard assumption was confirmed statistically for all
variables20 except anoxic brain injury; all models were subsequently
stratified on this factor. The first model incorporated race, age,
gender, income, education, region, metropolitan size, HMO or
Medicare Part B enrollment, admission year, comorbidity index,
preexisting CHF or coronary artery disease, admission diagnosis of
ventricular fibrillation, AMI, acute ischemia without infarction,
acute CHF, acute anoxic brain injury, admission to an ICD hospital
or revascularization hospital, length of stay, and discharge destina-
tion. Interactions between race, gender, age, and comorbidity were
also included. Our second model added coronary revascularization as
a time-dependent covariate. The final model included ICD implan-
tation as an additional time-dependent covariate.
Cardiac Procedures
To assess the effect of race on cardiac procedure utilization, we
constructed multinomial logistic regression models using predictors
that significantly differed between whites and blacks in univariate
analysis (ie, race, gender, age, region, income, education, admission
year, comorbidity index, ventricular fibrillation on admission, acute
ischemia without infarction, AMI, acute CHF, academic hospital
admission, and discharge destination) and interactions between age,
gender, race, and comorbidity. The 3 potential outcomes were (1)
survival to 90 days after index admission without receiving a
procedure, (2) death before 90 days without a procedure, and (3)
receipt of procedure within 90 days of admission. We separately
analyzed ICD implantation and receipt of either ICD implantation or
coronary revascularization.
Statistical Analyses
We used t tests to compare continuous variables except when data
were skewed, in which case logarithmic transformation or the
Wilcoxon rank-sum statistic was used. Categorical variables were
compared with the 
2 test or Fisher exact test. Comparisons between
the values of coefficients in nested multivariate models followed the
method of Clogg et al,21 with Bonferroni correction for multiple
pairwise comparisons. All analyses were performed with SAS
version 8.2. (SAS Institute). All significance tests were 2-sided. We
assumed a probability value of less than 0.05 was statistically
significant.
Results
Characteristics of the Study Cohort
A total of 7131 patients were identified initially. Of these,
1183 (17%) were subsequently excluded (Figure 1). There
was no statistically significant difference between the propor-
tion of whites or blacks excluded. Among the 5948 patients
ultimately included, the proportion of males was significantly
higher among whites than among blacks (Table 1). Black
patients lived in ZIP codes with lower levels of income and
education. Blacks also had significantly more comorbidity,
with higher rates of CHF, diabetes, hypertension, anemia, and
renal disease. Whites were more likely to be admitted for
ventricular fibrillation and to be diagnosed with AMI, cardiac
ischemia, or acute CHF. Black patients were more likely to be
admitted to an urban or major teaching hospital. Whites were
more likely to be discharged home.
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The patients were followed up for a median of 4.8 (interquar-
tile range 2.4 to 7.8) years. By December of 1999, 2970
patients (50%) had died, and 2244 (38%) were confirmed
alive. The remaining 734 patients (12%) were censored at a
median of 3.3 (interquartile range 1.9 to 5.3) years after the
index admission. There was no significant difference in the
proportion of whites and blacks censored before the end of
1999. ICDs were implanted in 820 survivors (14%), of whom
780 were white and 40 were black. Coronary revasculariza-
tion was performed in 716 survivors (12%), including 682
whites and 34 blacks.
Unadjusted Analyses
The unadjusted survival rate was significantly lower among
blacks (Figure 2). A total of 48% of all patients survived at
least 4 years after hospital discharge, yet life expectancy for
whites (4.1 years) was significantly longer than for blacks
(1.9 years; P0.0001 by log-rank test).
Adjusted Survival Analyses
In multivariate analyses, significant interaction was observed
between age and race (P0.0003) but not between race and
gender (P0.68) or between race and comorbidity (P0.78).
Models that controlled for demographic, clinical, and hospital
factors indicated no survival difference between whites and
blacks older than 75 years (Table 2). In contrast, higher
mortality risk for younger blacks persisted despite control for
these covariates. The addition of coronary revascularization
and ICD implantation to the model resulted in a significant
decrease in the hazard ratio (HR) for younger blacks from
1.30 to 1.23 (P0.0001 for the difference).
Cardiac Procedures
Survival analyses stratified by race indicated that ICD im-
plantation was independently associated with reduced long-
term mortality among both black (HR 0.50, 95% CI 0.27 to
0.91) and white (HR 0.53, 95% CI 0.45 to 0.62) patients. In
contrast, coronary revascularization was associated with
lower mortality among whites (HR 0.48, 95% CI 0.40 to
0.57) but not among blacks (HR 1.32, 95% CI 0.76 to 2.29).
More than 90% of ICD patients underwent implantation
within 90 days of admission. Younger patients were nearly
twice as likely as older patients to receive procedures. In
multivariate models that examined procedure rates, interac-
tion was not observed between race and age (P0.15), race
and gender (P0.84), or race and comorbidities (P0.71).
Blacks aged 66 to 74 years were significantly less likely to
receive an ICD by 90 days than whites (OR 0.58, 95% CI
0.36 to 0.94). For the combined outcome of ICD implantation
or coronary revascularization by 90 days, younger blacks
again had substantially lower odds than whites of receiving at
least 1 procedure (OR 0.50, 95% CI 0.34 to 0.75). No racial
differences were noted in ICD implantations or in combined
procedure rates among patients aged 75 years and older.
Discussion
Among elderly survivors of cardiac arrest, blacks aged 66 to
74 years have a lower probability of receiving potentially
life-saving cardiac procedures and have reduced long-term
survival. These disparities persist despite adjustment for
socioeconomic differences, comorbidities, admission charac-
teristics, clinical events, and hospital factors. In fact, a
substantial portion of the remaining survival disparity may be
explained by the differing procedure rates; the observed
change in HR for younger blacks suggests that 7% of excess
adjusted mortality might be attributable to underuse of
procedures. Because mortality rates among cardiac arrest
survivors are generally high, increasing use of cardiac pro-
cedures among younger blacks may save several additional
lives per year.
The present study identifies a substantial racial disparity in
the clinical use of effective and common medical technolo-
gies. Although this analysis was not designed to determine
the causes of such disparity, previous investigators have
identified patient preferences, mistrust, patient-provider com-
munication, cultural issues, provider bias, and systemic ineq-
uities as potential contributors to racial disparities in medical
care.15
ICD implantation may be more clinically appropriate if
ventricular fibrillation can be determined as the cause of
cardiac arrest; conversely, implantation may be less appro-
priate in the setting of evolving myocardial infarction.22
Although younger blacks had fewer documented episodes of
cardiac ischemia and ventricular fibrillation than whites, our
Figure 1. Exclusion criteria applied to patients hospitalized for
cardiac arrest or ventricular ﬁbrillation and discharged alive.
Block arrows represent successive application of exclusion cri-
teria. Line arrows indicate numbers of excluded patients, strati-
ﬁed by race. EPS indicates electrophysiological study.
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Whites
(n5429)
Blacks
(n519) P
Demographic characteristics
Age, mean (SD), y 76 (7) 76 (8) NS
Female gender 2157 (40) 318 (61) 0.0001
Per capita income, median (IQR), $ 13 700 (11 600–16 800) 12 300 (9900–14 900) 0.0001
Education, mean (SD), y 13.7 (1.3) 12.3 (1.1) 0.0001
Region 0.0001†
Northeast 1240 (23) 83 (16)
Midwest 1518 (28) 145 (28)
South 1526 (28) 243 (47)
West 1145 (21) 48 (9)
Admitted 1995–1999 2565 (47) 253 (49) NS
HMO‡ 266 (5) 28 (5) NS
Medicare Part B‡ 4991 (92) 465 (90) NS
Clinical characteristics
Comorbidity index, median (IQR) 0 (0–1.2) 1.2 (0–2.4) 0.0001
Selected comorbidities§
Anemia 478 (9) 100 (19) 0.0001
CHF 1680 (31) 205 (39) 0.0001
Coronary artery disease 1136 (21) 112 (22) NS
Diabetes without complications 617 (11) 111 (21) 0.0001
Diabetes with complications 64 (1) 30 (6) 0.0001
Hemiplegia/paraplegia 34 (1) 12 (2) 0.0004
Hypertension 1034 (19) 171 (33) 0.0001
Metastatic cancer 51 (1) 16 (3) 0.001
Renal disease 191 (4) 78 (15) 0.0001
Index hospitalization
Admitted for ventricular fibrillation 1290 (24) 82 (16) 0.0001
Myocardial ischemia or infarction 2212 (41) 143 (28) 0.0001
Acute CHF 2367 (44) 202 (39) 0.04
Anoxic brain injury 1501 (28) 124 (24) NS
Length of stay, median (IQR) 11 (7–18) 12 (8–20) NS
Population, hospital location 0.0001†
100 000 959 (18) 72 (14)
100 001–500 000 1391 (25) 115 (22)
500 001–1 000 000 815 (15) 79 (15)
1 000 000 2264 (42) 253 (49)
Academic hospital 768 (14) 137 (26) 0.0001
ICD hospital¶ 1561 (29) 163 (31) NS
Revascularization hospital¶ 2698 (50) 276 (53) NS
Discharge destination
Home 4362 (80) 386 (74) 0.003†
Skilled nursing facility 740 (14) 97 (19)
Intermediate-care facility 327 (6) 36 (7)
IQR indicates interquartile range.
*Unless otherwise indicated, data appear as number (percentage).
†P for 2 of distribution among categories.
‡Enrolled during index hospitalization.
§Other Charlson comorbidity categories with no significant racial differences.
Member of the Council of Teaching Hospitals.
¶Hospital reported performing procedure during year subject was admitted.
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showed persistent racial disparities. The present study ex-
cluded patients with the admission diagnosis of ventricular
tachycardia, yet fewer than 2% of out-of-hospital cardiac
arrest patients have ventricular tachycardia.23
To our knowledge, this was the first nationally represen-
tative cohort of cardiac arrest survivors assembled in the
medical literature. The 10-year enrollment period enabled
precise estimation of life expectancy and the pattern of
survival. We enrolled substantial numbers of black patients,
which was essential in identifying race as a risk factor for
both lower procedure rates and early mortality. Our multivar-
iate models controlled for multiple demographic, socioeco-
nomic, and clinical factors that might confound the associa-
tion between race, survival, and procedure utilization.
Because ICDs are increasingly recognized as first-line ther-
apy for cardiac arrest survivors, our results highlight the
importance of eliminating barriers to procedure utilization
among blacks.
The present study is also the first to find comparable
clinical benefit of the ICD in both black and white survivors.
Therefore, increasing ICD utilization among appropriate
black patients may improve health outcomes. The finding that
revascularization was not associated with prolonged survival
among blacks may simply be a reflection of small sample size
(only 34 black patients [6.5%] underwent revascularization),
or it may represent differences in the causes of cardiac arrest
among blacks and whites. The difference in gender propor-
tions between whites and blacks is possibly due to the
“selection effect” of cardiac arrest, which may reduce sur-
vival in patients with worse general health (eg, elderly black
men). Regardless, our multivariate models controlled for
gender directly and in interaction with other variables; thus,
the racial disparities we observed cannot be explained by
differences in gender proportion.
Comparisons With Prior Cardiac Arrest Studies
The Cardiac Arrest Study Hamburg trial followed 288 survi-
vors of cardiac arrest who were assigned to either ICD
implantation or antiarrhythmic drug therapy.6 The 4-year
mortality rate was 31%, which was substantially lower than
the 52% we observed. The selective entry criteria for such
clinical trials complicate the application of results to the
general population. The present population-based study is
more likely to reflect the outcomes experienced by the
majority of elderly American cardiac arrest survivors. In their
cohort analysis, Cobbe et al8 noted that 56% of 321 cardiac
arrest survivors over the age of 65 years remained alive at 4
years, which was similar to the 48% 4-year survival rate that
we observed. The present study broadens these findings with
its greater capacity to examine the effect of race on clinical
outcomes.
Comparisons With Prior Racial Disparity Studies
Previous studies of ICDs and racial disparity used California
hospital discharge abstracts from the early 1990s to demon-
strate that blacks may receive fewer procedures.24,25 The
present study extends these findings by focusing on a high-
risk cohort (cardiac arrest survivors) by use of a national
sample, recording procedures from throughout the 1990s, and
following patients for a substantially longer duration.
Data Limitations
Some comorbidities may be underreported or unobservable in
administrative records. If blacks had disproportionately more
unreported comorbidity than whites, this may explain lower
procedure rates and reduced survival among blacks, as well as
the larger reduction in mortality due to ICDs noted in the
present study (47% to 50%) compared with clinical trial
results (25% to 30%).5,6 However, we used a well-validated
method for risk adjustment of administrative data, and we
found no interaction between observed comorbidity and race,
as would be expected if comorbidity were underestimated for
blacks. Furthermore, all patients in the clinical trials received
efficacious treatments, and differences in efficacy were as-
sessed in intention-to-treat analyses. The present analysis,
which compared survival among actual ICD recipients to all
Figure 2. Unadjusted Kaplan-Meier survival estimates for black
and white cardiac arrest survivors. The y-axis is proportion of
cohort surviving at time from cardiac arrest indicated on x-axis.
TABLE 2. Effect of Race on Long-Term Survival: Hazard Ratios
from Multivariate Analyses
Age, y HR* 95% CI P
Demographic and clinical variables only
66–74 1.30† 1.09–1.55 0.003
75 0.88 0.74–1.06 0.18
Plus revascularization
66–74 1.28† 1.07–1.52 0.006
75 0.85 0.71–1.02 0.08
Plus ICD implantation
66–74 1.23† 1.03–1.46 0.02
75 0.86 0.72–1.03 0.10
*Mortality HR for blacks compared with whites in same age strata.
†Differs significantly (P0.001) from corresponding HR in prior model.
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to yield a larger treatment difference.
The present study used administrative data, which can be
less accurate than medical records or data from prospective
clinical trials. Administrative data are insufficiently detailed
to precisely identify contraindications to ICD use; however,
because these are closely correlated to the cardiac diagnoses
and comorbidities incorporated in our models, we believe any
bias introduced by racial differences in contraindications
would be minimal. Although we could not validate our data
with medical records, MEDPAR data have been found to be
reliable for major medical diagnoses and procedures,26 and
racial disparity studies using administrative data have fre-
quently found results comparable to those that used clinical
databases.13 We also used aggregate measures of education
and income; residual differences among individuals may have
confounded our results. Additionally, patients who received
cardiac procedures may have been admitted to higher-quality
hospitals. However, inclusion of variables indicating the
technological capacity of the admitting hospital did not
weaken the association between the actual procedures and
survival, as would be expected if differences in healthcare
quality, rather than procedures, produced the survival dispar-
ity. Finally, the observation that our mortality HR for younger
blacks remained at 1.23 in our full survival model suggests
that we did not account for all possible factors related to both
race and mortality; indeed, factors such as health-related
behaviors or patient preferences were unobservable. It is
possible that the inclusion of such variables could diminish
the observed effect of procedures on mortality.
Design Limitations
Because this was an observational study, the association we
found between lower procedure rates and survival may not
necessarily be causal. Yet, because the number of nonwhites
surviving cardiac arrest is not large, an observational analysis
with a large national database may be the only feasible
method of examining racial differences in healthcare out-
comes. Finally, because all patients in the present study were
black or white and over the age of 65 years, caution should be
exercised in applying the results outside of this population.
Conclusions
Blacks aged 66 to 74 years do not live as long after cardiac
arrest as white patients. Some of this disparity can be
explained by differential rates of cardiac procedures such as
revascularization and ICDs. This result, combined with racial
disparity in the use of ICDs in younger but not older Medicare
beneficiaries, implies that expanded use of effective proce-
dures in black patients would substantially reduce racial
differences in long-term survival.
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